SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-025405
Filing Date
2018-04-18
Accepted
2018-04-18 17:06:54
Documents
2
Period of Report
2018-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2181
2 POA DOCUMENT poa.txt EX-24.3_784301 3685
  Complete submission text file 0001209191-18-025405.txt   7249
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Issuer) CIK: 0001423824 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ALDER BIOPHARMACEUTICALS, INC. 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address
Lavelle Erin (Reporting) CIK: 0001737613 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36431 | Film No.: 18761774